Physician profile
Thomas J Coffman
NPI 1245224823
$837.94
in general payments reported to CMS, 2019-2025
9 companies · $73.22 in 2025
The $73.22 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $252 · 2021: $88.28 · 2022: $99.68 · 2023: $49.07 · 2024: $89.22 · 2025: $73.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $217.83 | 2020-2022 | |
| La Jolla Pharmaceutical Company | $204.18 | 2021-2025 | Xacduro |
| Kci USA, INC. | $134.13 | 2020 | |
| Hologic Sales and Service, LLC | $119.87 | 2019 | |
| Janssen Pharmaceuticals, INC | $49.07 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $36.00 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $30.32 | 2019 | |
| Abbvie INC. | $23.70 | 2024 | |
| Gilead Sciences, INC. | $22.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Coffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.